» Articles » PMID: 16190943

Tuberous Sclerosis Complex and the Ketogenic Diet

Overview
Journal Epilepsia
Specialty Neurology
Date 2005 Sep 30
PMID 16190943
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Tuberous sclerosis complex (TSC) is a condition that is frequently associated with intractable, early-onset epilepsy, and often is first seen as infantile spasms. If medications fail and no clear epileptogenic tuber is identified, nonpharmacologic therapies are often attempted. The use of the ketogenic diet specifically for children with TSC and epilepsy has not been previously described.

Methods: A chart review was performed of patients with TSC treated with the ketogenic diet over a 5-year period at Johns Hopkins Hospital and Massachusetts General Hospital.

Results: Twelve children, ages 8 months to 18 years, were identified. Eleven (92%) children had a >50% reduction in their seizures at 6 months on the diet, and 8 (67%) had a >90% response. Five children had at least a 5-month seizure-free response. Diet duration ranged from 2 months to 5 years (mean, 2 years).

Conclusions: In this limited-duration case series of 12 patients, the ketogenic diet was a generally effective therapeutic modality for the intractable epilepsy occasionally seen in children with TSC.

Citing Articles

Ketogenic Diet: Parental Experiences and Expectations.

Orr E, Whitney R, Nandeesha N, Kossoff E, Ramachandrannair R J Child Neurol. 2024; 39(1-2):45-54.

PMID: 38314711 PMC: 11083737. DOI: 10.1177/08830738241227066.


A Novel Genetic Variant in Associated with Severe Epilepsy and Intellectual Disability: Potential Implications on Neural Primary Cilia.

Martins M, Oliveira A, Martins S, Vieira J, Perdigao P, Fernandes A Int J Mol Sci. 2023; 24(16).

PMID: 37628781 PMC: 10454663. DOI: 10.3390/ijms241612603.


Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review.

Menezes C, Santos D, Nery E, Serpa E, Morais L, Dutra L Arq Neuropsiquiatr. 2023; 81(4):392-398.

PMID: 36863402 PMC: 10169230. DOI: 10.1055/s-0042-1758442.


Ketogenic Diet Therapy for Drug-Resistant Epilepsy and Cognitive Impairment in Children With Tuberous Sclerosis Complex.

Fang Y, Li D, Wang M, Zhao X, Duan J, Gu Q Front Neurol. 2022; 13:863826.

PMID: 35685742 PMC: 9171393. DOI: 10.3389/fneur.2022.863826.


The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.

Vanclooster S, Bissell S, Van Eeghen A, Chambers N, Waele L, Byars A J Neurodev Disord. 2022; 14(1):13.

PMID: 35151277 PMC: 8853020. DOI: 10.1186/s11689-022-09423-3.